Cancer news

Patients with a certain type of aggressive skin cancer will now have access to a combination of targeted drugs on the NHS in England.

Scientists have discovered that testing skin cancer patients’ blood for tumour DNA could help predict the chances of an aggressive cancer returning.

The type of bacteria in the gut of patients with advanced melanoma may influence their response to a certain type immunotherapy, according to new research.

We’d like to introduce the latest bunch of scientists that we’ve given funding to head up their own research teams for the first time.

Two clinical trials have found that existing treatments for advanced melanoma could stop the cancer returning in some people with earlier stage disease.

Viruses may improve the success rate of immunotherapy treatments, according to two new studies.

Dave lost his twin brother to skin cancer at just 28. Here, Dave tells us Mark’s inspiring story through his cancer.

Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.

A combination of two immunotherapy drugs is safe to give to patients with melanoma that has spread to the brain, and could help control the disease.

For Sun Awareness Week we're tackling 10 persistent sun safety myths, and encouraging people to think about how they can stay safe in the sun.